Tempus AI, Inc. (TEM)
64.04
-6.65
(-9.41%)
USD |
NASDAQ |
Aug 28, 16:00
63.41
-0.63
(-0.98%)
After-Hours: 20:00
Tempus AI Cash from Operations (Quarterly) : -8.05M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.05M |
| March 31, 2026 | -73.50M |
| December 31, 2025 | -36.79M |
| September 30, 2025 | -119.84M |
| June 30, 2025 | 44.16M |
| March 31, 2025 | -105.62M |
| December 31, 2024 | -39.25M |
| September 30, 2024 | 48.66M |
| June 30, 2024 | -97.08M |
| March 31, 2024 | -101.38M |
| December 31, 2023 | -40.27M |
| September 30, 2023 | -52.98M |
| Date | Value |
|---|---|
| June 30, 2023 | -54.82M |
| March 31, 2023 | -66.26M |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | -63.76M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -44.99M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Personalis, Inc. | -25.77M |
| 10X Genomics, Inc. | 16.97M |
| Twist Bioscience Corp. | 1.115M |
| Alamar Biosciences, Inc. (California) | -11.32M |
| IQVIA Holdings, Inc. | 558.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -11.09M |
| Cash from Financing (Quarterly) | 97.65M |
| Free Cash Flow | -273.72M |
| Free Cash Flow Per Share (Quarterly) | -0.1049 |
| Free Cash Flow to Equity (Quarterly) | -144.78M |
| Free Cash Flow to Firm (Quarterly) | -9.220M |
| Free Cash Flow Yield | -2.39% |